Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Yang

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|July 18, 2018
FOXP3 Activates SUMO-Conjugating <i>UBC9</i> Gene in MCF7 Breast Cancer CellsChiung-Min Wang, William H Yang, Runhua Liu, et al.
Plos One|September 1, 2017
The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational studyMohit Bhutani, William H Yang, Jacques Hébert, et al.
International Archives of Allergy and Immunology|April 8, 2025
Clinical Response to Cat Allergen in a Mobile Compared to a Fixed Naturalistic Exposure Chamber™Laura Haya, Suzanne Kelly, Stefan Van de Mosselaer, et al.
The Journal of Allergy and Clinical Immunology|June 13, 2016
Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamberMichel Roux, Philippe Devillier, William H Yang, et al.
Cancers|March 13, 2024
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2Kasey Price, William H Yang, Leticia Cardoso, et al.
Vaccine|July 17, 2013
Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trialWilliam H Yang, Marc Dionne, Michael Kyle, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2008
Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety studyWilliam H Yang, Jean Benoit Martinot, Petr Pohunek, et al.
The Journal of Allergy and Clinical Immunology|September 4, 2018
Fel d 1 and Fel d 4 levels in cat fur, saliva, and urineSuzanne M Kelly, Jacob Karsh, Jennifer Marcelo, et al.
Allergy|October 23, 2021
Automated dander dispersal in a cat Naturalistic Exposure Chamber (NEC)Laura Kilford Haya, Rym Mehri, Shawn Somers-Neal, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) ExpressionWilliam H Yang, Andrew P George, Chiung-Min Wang, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|July 18, 2018
FOXP3 Activates SUMO-Conjugating <i>UBC9</i> Gene in MCF7 Breast Cancer CellsChiung-Min Wang, William H Yang, Runhua Liu, et al.
Plos One|September 1, 2017
The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational studyMohit Bhutani, William H Yang, Jacques Hébert, et al.
International Archives of Allergy and Immunology|April 8, 2025
Clinical Response to Cat Allergen in a Mobile Compared to a Fixed Naturalistic Exposure Chamber™Laura Haya, Suzanne Kelly, Stefan Van de Mosselaer, et al.
The Journal of Allergy and Clinical Immunology|June 13, 2016
Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamberMichel Roux, Philippe Devillier, William H Yang, et al.
Cancers|March 13, 2024
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2Kasey Price, William H Yang, Leticia Cardoso, et al.
Vaccine|July 17, 2013
Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trialWilliam H Yang, Marc Dionne, Michael Kyle, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2008
Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety studyWilliam H Yang, Jean Benoit Martinot, Petr Pohunek, et al.
The Journal of Allergy and Clinical Immunology|September 4, 2018
Fel d 1 and Fel d 4 levels in cat fur, saliva, and urineSuzanne M Kelly, Jacob Karsh, Jennifer Marcelo, et al.
Allergy|October 23, 2021
Automated dander dispersal in a cat Naturalistic Exposure Chamber (NEC)Laura Kilford Haya, Rym Mehri, Shawn Somers-Neal, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) ExpressionWilliam H Yang, Andrew P George, Chiung-Min Wang, et al.
Pageof 5